The significance of this is unclear, but it could represent a change in expression that promotes metastatic disease, influence from the tumor microenvironment at metastatic sites resulting in overexpression of PRSS21, or suggest that overexpression of PRSS21 correlates to more aggressive biology and a higher propensity for metastatic disease. The gene discussed is PRSS21; the disease is metastatic neoplasm.